Individualised gonadotropin dose selection using markers of ovarian reserve for women undergoing IVF/ICSI

Sarah F. Lensen*, Jack Wilkinson, Ben Willem J. Mol, Antonio La Marca, Helen Torrance, Frank J. Broekmans

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

10 Citations (Scopus)

Abstract

This is a protocol for a Cochrane Review (Intervention). The objectives are as follows: This review has two objectives. These are: to assess the comparative effectiveness (pregnancy and live birth) and safety (ovarian hyperstimulation syndrome) in women undergoing in vitro fertilisation/intracytoplasmic sperm injection (IVF/ICSI): of different doses of gonadotropin in women subgrouped by their expected response to stimulation, as defined by at least one ovarian reserve test (ORT) measure (do women with low, moderate or high anticipated response to ovarian stimulation, based on an ORT, benefit from a modified gonadotropin dose?); and of individualisation of gonadotropin dose using ORT, as compared to dose selection without ORT, or to an alternative individualised dosing algorithm using ORT (does using ORT to individualise gonadotropin dose improve IVF/ICSI outcomes, and is there evidence to suggest one algorithm is better than another?).

Original languageEnglish
Article numberCD012693
JournalCochrane Database of Systematic Reviews
Volume2017
Issue number6
Early online date19 Jun 2017
DOIs
Publication statusPublished - 19 Jun 2017

Fingerprint

Dive into the research topics of 'Individualised gonadotropin dose selection using markers of ovarian reserve for women undergoing IVF/ICSI'. Together they form a unique fingerprint.

Cite this